Journal
CANCER AND METASTASIS REVIEWS
Volume 19, Issue 1-2, Pages 181-190Publisher
SPRINGER
DOI: 10.1023/A:1026551202548
Keywords
antiangiogenesis; Angiostatin; Endostatin
Categories
Ask authors/readers for more resources
Considerable progress has been made in the understanding of the molecular structure and mechanistic aspects of Angiostatin and Endostatin, endogenous angiogenesis inhibitors that have been shown to regress tumors in murine models. The growing body of literature surrounding these molecules and on the efficacy of these proteins is in part due to the ability to generate these proteins in recombinant systems as well characterized molecules. Recombinant human Angiostatin and Endostatin are in Phase I trials, following the manufacture of clinical grade material at large scale. This review highlights the recent advances made on understanding the structure and function of Angiostatin and Endostatin.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available